Opdivo

Opdivo®

Opdivo® (nivolumab) is a prescription medicine administered by intravenous infusion for treatment of 12 different types of cancer by working with your immune system.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

Opdivo® Referral Form

MANUFACTURER:

Bristol-Myers Squibb

CLASS:
Checkpoint Inhibitors
WHAT IT TREATS:
PRESCRIBED BY:

Oncologists

HOW ADMINISTERED:
IV Infusion
FREQUENCY:

Every four to six weeks

Length of infusion:
30 mins